Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Department of Public Health, Experimental and Forensic Medicine, Section of Hygiene, University of Pavia, Pavia, Italy.
Hum Vaccin Immunother. 2021 Dec 2;17(12):5007-5012. doi: 10.1080/21645515.2021.1984123. Epub 2021 Oct 13.
Assessing vaccine hesitancy and its determinants is pivotal to optimize vaccine acceptance in anticoagulated patients, given that this population has been described to have a higher risk of severe COVID-19-related complications. This study assessed the moderator role of patients' health engagement on the relationship between health literacy and vaccine hesitancy. A web-based survey was performed in Italy during the first wave (June-August 2020) and the second wave (October 2020-March 2021) of the COVID-19 pandemic, enrolling 288 patients. The rates of vaccine hesitancy reported during the first pandemic wave were 38.4% and 30.8% during the second wave (when a vaccine was available) ( = .164). A moderation analysis was performed to assess the role of health engagement in influencing the relationship from health literacy to vaccine hesitancy. Patients' health engagement enhanced the effects of health literacy on decreasing vaccine hesitancy ( < .001), suggesting that co-construction strategies for communicative action are pivotal.
评估疫苗犹豫及其决定因素对于优化抗凝患者的疫苗接种至关重要,因为该人群被描述为具有更高的 COVID-19 相关严重并发症风险。本研究评估了患者健康参与度在健康素养与疫苗犹豫之间关系中的调节作用。在 COVID-19 大流行的第一波(2020 年 6 月至 8 月)和第二波(2020 年 10 月至 2021 年 3 月)期间,在意大利进行了一项基于网络的调查,共纳入 288 名患者。第一波大流行期间报告的疫苗犹豫率为 38.4%,第二波期间(当有疫苗可用时)为 30.8%( =.164)。进行了一项调节分析,以评估健康参与度在影响健康素养与疫苗犹豫关系中的作用。患者的健康参与度增强了健康素养对降低疫苗犹豫的影响( <.001),这表明沟通行动的共同构建策略至关重要。